E-prescribing Market Size To Reach $27.6 Billion By 2033

October 2026 | Report Format: Electronic (PDF)

E-Prescribing Market Growth & Trends

The global E-prescribing market size is expected to reach USD 27.6 billion by 2033, registering a CAGR of 21.0% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing emphasis on reduction of drug abuse & fraud, rising initiatives by the government to digitalize healthcare systems, and growing efforts on reducing medication errors are the major factors driving growth. However, high initial investment and resistance to the adoption of new technology, by both patients & healthcare providers, restrain growth. On the other hand, improving healthcare infrastructure and increasing healthcare expenditure in developing countries are anticipated to provide numerous growth opportunities for the market. Moreover, using Electronic Healthcare Records (EHRs) with e-prescribing increases the growth potential.

Healthcare providers have increased interoperability tool adoption for boosting price transparency, healthcare management, and specialty medications, during the COVID-19 pandemic. The pandemic sparked the adoption of virtual healthcare and the e-prescribing market witnessed a 72.5% increase in the number of electronic prescriptions, along with the adoption of telehealth, during the starting months of the outbreak.

E-prescribing is widely used in the preparation and maintenance of complete medication lists. Moreover, the technology also aids the extraction of complete patient information and formulary with continuous data security checks. These services are gaining traction due to the increasing application of technology in the healthcare sector and significant support from governments across the world. For instance, government initiatives include incentive programs to promote e-prescribing, such as the National Council for Prescription Drugs Program and the Clinical Health Act in North America.

Key players in the market are investing in the launch of new products and collaborations for sustaining the market. For instance, in August 2021, Surescripts collaborated with GoodRx, an American company that allows resources to ensure healthcare savings. The collaboration delivered drug discount price information to prescribers using the Surescripts Real-Time Prescription Benefit while prescribing medications for patients who do not have insurance.

key Request a free sample copy or view report summary: E-Prescribing Market Report

E-Prescribing Market Report Highlights

By product, the solutions segment held the largest market share of 56.9% in 2025.The services segment is anticipated to grow at the fastest CAGR of 23.4% over the forecast period.
By delivery mode, the web/cloud based segment dominated the market with a revenue share of 62.9% in 2025.The on-premises segment is expected to grow at the fastest CAGR from 2026 to 2033.
By end-use, the hospitals segment led the market with the largest revenue share of 37.8% in 2025.The pharmacy segment is anticipated to grow at the fastest CAGR during the forecast period.
By specialties, the sports medicine segment dominated the market with a revenue share of 23.3% in 2025.The cardiology segment is anticipated to grow at the fastest CAGR during the forecast period from 2026 to 2033.
By usage methods, the handheld segment accounted for the largest market revenue share in 2025.The computer-based devices segment is expected to grow at the fastest CAGR during the forecast period.
Bysubstances, the controlled substances segment accounted for the largest market revenue share in 2025. The non-controlled substances segment is anticipated to grow at the fastest CAGR of 28.6% from 2026 to 2033.

E-Prescribing Market Segmentation

Grand View Research has segmented global e-prescribing market report based on the product, delivery mode, end-use, usage method, substance, specialties, and region:

E-prescribing Product Outlook (Revenue, USD Billion, 2021 - 2033)